医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2013年
29期
657-659
,共3页
蔡海鸿%王伟%刘和龙%胡其图%张勇
蔡海鴻%王偉%劉和龍%鬍其圖%張勇
채해홍%왕위%류화룡%호기도%장용
颅脑损伤%凝血-纤溶指标%哥拉斯哥昏迷评分%进展性颅内出血
顱腦損傷%凝血-纖溶指標%哥拉斯哥昏迷評分%進展性顱內齣血
로뇌손상%응혈-섬용지표%가랍사가혼미평분%진전성로내출혈
Craniocerebral injury%Blood coagulation-fibrinolytic indexes%Glasgow Coma Score%Advanced hemorrhagic lesions
颅脑损伤是一种常见的、死残率较高的损伤,而颅脑损伤后凝血-纤溶功能异常的发生率40%~80%,在中、重型颅脑损伤中,凝血异常发生率为27%~93%[1]。如何降低颅脑损伤患者的死、残率,提高患者生存质量,是目前神经外科的研究重点之一。而凝血-纤溶指标紊乱是颅脑损伤常见并发症,可加重脑损害并影响患者预后,对这些指标进行监测,有利于临床治疗策略的制定及对预后的评估。本文就颅脑损伤后凝血-纤溶指标变化机制,其对患者预后评估价值及目前针对颅脑损伤后凝血功能不全的治疗作一综述。
顱腦損傷是一種常見的、死殘率較高的損傷,而顱腦損傷後凝血-纖溶功能異常的髮生率40%~80%,在中、重型顱腦損傷中,凝血異常髮生率為27%~93%[1]。如何降低顱腦損傷患者的死、殘率,提高患者生存質量,是目前神經外科的研究重點之一。而凝血-纖溶指標紊亂是顱腦損傷常見併髮癥,可加重腦損害併影響患者預後,對這些指標進行鑑測,有利于臨床治療策略的製定及對預後的評估。本文就顱腦損傷後凝血-纖溶指標變化機製,其對患者預後評估價值及目前針對顱腦損傷後凝血功能不全的治療作一綜述。
로뇌손상시일충상견적、사잔솔교고적손상,이로뇌손상후응혈-섬용공능이상적발생솔40%~80%,재중、중형로뇌손상중,응혈이상발생솔위27%~93%[1]。여하강저로뇌손상환자적사、잔솔,제고환자생존질량,시목전신경외과적연구중점지일。이응혈-섬용지표문란시로뇌손상상견병발증,가가중뇌손해병영향환자예후,대저사지표진행감측,유리우림상치료책략적제정급대예후적평고。본문취로뇌손상후응혈-섬용지표변화궤제,기대환자예후평고개치급목전침대로뇌손상후응혈공능불전적치료작일종술。
Craniocerebral injury is a common injury, the death rate is higher, and dysfunction of blood coagulation, fibrinolytic after craniocerebral injury incidence of 40%80%, in the medium and heavy craniocerebral injury, coagulation abnormality rate was 27%~93% [1].How to reduce the rate of death in patients with craniocerebral injury and residual rate, improve the quality of survival, is one of the research focus of neurosurgery at present. And coagulation, fibrinolytic indexes disorder is a common complication, craniocerebral injury can worsen the prognosis of patients with brain damage and impact, to monitor these metrics, is helpful to clinical treatment strategy formulation and evaluation of prognosis. In this paper, the coagulation, fibrinolytic indexes change after craniocerebral injury mechanisms, and prognosis of patients with the assessed value of the current and blood coagulation dysfunction treatment after craniocerebral injury.